NO955047D0 - Sekundære aminer som antidiabetiske og antifedme-midler - Google Patents
Sekundære aminer som antidiabetiske og antifedme-midlerInfo
- Publication number
- NO955047D0 NO955047D0 NO955047A NO955047A NO955047D0 NO 955047 D0 NO955047 D0 NO 955047D0 NO 955047 A NO955047 A NO 955047A NO 955047 A NO955047 A NO 955047A NO 955047 D0 NO955047 D0 NO 955047D0
- Authority
- NO
- Norway
- Prior art keywords
- pct
- antidiabetic
- date dec
- secondary amines
- obesity agents
- Prior art date
Links
- 239000000883 anti-obesity agent Substances 0.000 title abstract 2
- 239000003472 antidiabetic agent Substances 0.000 title abstract 2
- 229940125710 antiobesity agent Drugs 0.000 title abstract 2
- 230000003178 anti-diabetic effect Effects 0.000 title 1
- 229940125708 antidiabetic agent Drugs 0.000 title 1
- 150000003335 secondary amines Chemical class 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 235000020997 lean meat Nutrition 0.000 abstract 2
- 230000008021 deposition Effects 0.000 abstract 1
- 229940126904 hypoglycaemic agent Drugs 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fodder In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7602693A | 1993-06-14 | 1993-06-14 | |
| PCT/IB1994/000117 WO1994029290A1 (en) | 1993-06-14 | 1994-05-20 | Secondary amines as antidiabetic and antiobesity agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO955047L NO955047L (no) | 1995-12-13 |
| NO955047D0 true NO955047D0 (no) | 1995-12-13 |
Family
ID=22129472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO955047A NO955047D0 (no) | 1993-06-14 | 1995-12-13 | Sekundære aminer som antidiabetiske og antifedme-midler |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5767133A (no) |
| EP (1) | EP0703911B1 (no) |
| JP (1) | JPH08506348A (no) |
| KR (1) | KR960703120A (no) |
| CN (1) | CN1129443A (no) |
| AT (1) | ATE154935T1 (no) |
| AU (1) | AU675536B2 (no) |
| BR (1) | BR9406823A (no) |
| CA (1) | CA2164009A1 (no) |
| CZ (1) | CZ327795A3 (no) |
| DE (1) | DE69404039T2 (no) |
| DK (1) | DK0703911T3 (no) |
| ES (1) | ES2104383T3 (no) |
| FI (1) | FI942791A (no) |
| GR (1) | GR3024134T3 (no) |
| HU (1) | HUT70844A (no) |
| IL (1) | IL109904A0 (no) |
| NO (1) | NO955047D0 (no) |
| NZ (1) | NZ265692A (no) |
| PL (1) | PL312005A1 (no) |
| WO (1) | WO1994029290A1 (no) |
| ZA (1) | ZA944139B (no) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5541197A (en) * | 1994-04-26 | 1996-07-30 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| CA2171702A1 (en) * | 1995-03-14 | 1996-09-15 | Takashi Sohda | Benzofuran compounds and their use |
| WO1996035670A1 (en) * | 1995-05-10 | 1996-11-14 | Pfizer Inc. | β-ADRENERGIC AGONISTS |
| WO1996035671A1 (en) * | 1995-05-10 | 1996-11-14 | Pfizer Inc. | β-ADRENERGIC AGONISTS |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| GB2305665A (en) * | 1995-09-26 | 1997-04-16 | Merck & Co Inc | Selective ß3 agonists for the treatment of diabetes aand obesity |
| TR199800710T2 (xx) * | 1995-10-31 | 1998-08-21 | Pfizer Inc. | 1-(2(2-izoksazol-3-ilbenzofuran-5-iloksi) ethilamino)-3-fenoksi-2(S)-ol haz�rlanmas� i�in i�lem ve ara maddeler. |
| PT882707E (pt) | 1996-01-10 | 2004-02-27 | Asahi Chemical Ind | Novos compostos trciclicos e composicoes medicamentosas contendo os mesmos |
| US6031105A (en) * | 1996-04-09 | 2000-02-29 | Pfizer Inc | Substituted pyridines |
| US6008361A (en) * | 1996-04-09 | 1999-12-28 | Pfizer Inc. | Substituted pyridines |
| EP0801060A1 (en) * | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclic Beta-3 Adrenergenic Agonists |
| EP0822185A1 (en) * | 1996-07-31 | 1998-02-04 | Pfizer Inc. | B-3-adrenergic agonists as antidiabetic and antiobesity agents |
| US5808080A (en) * | 1996-09-05 | 1998-09-15 | Eli Lilly And Company | Selective β3 adrenergic agonists |
| ES2171839T3 (es) | 1996-09-05 | 2002-09-16 | Lilly Co Eli | Analogos de carbazol como agonistas adrenergicos selectivos de beta3. |
| ATE247641T1 (de) * | 1996-11-14 | 2003-09-15 | Pfizer | Pyridin-zwischenprodukte, verwendbar zur herstellung von beta-adrenergischen rezeptor- agonisten |
| DE69735433D1 (de) * | 1996-11-14 | 2006-05-04 | Pfizer | Verfahren zur herstellung von substituierten pyridinen |
| AU6852898A (en) * | 1997-04-17 | 1998-11-11 | Takeda Chemical Industries Ltd. | Thermogenic composition and benzazepine thermogenics |
| AU735249B2 (en) * | 1997-07-03 | 2001-07-05 | Asahi Kasei Kabushiki Kaisha | Novel tricyclic compounds having saturated rings and medicinal compositions containing the same |
| CO5011072A1 (es) * | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
| US6051586A (en) * | 1997-12-19 | 2000-04-18 | Bayer Corporation | Sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| US6469031B1 (en) | 1998-12-18 | 2002-10-22 | Bayer Corporation | Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| CN1284952A (zh) * | 1997-12-19 | 2001-02-21 | 美国拜尔公司 | 用作β3肾上腺素能受体激动剂的羧基取代苯并二氢吡喃类衍生物 |
| US6121271A (en) * | 1998-05-12 | 2000-09-19 | American Home Products Corporation | Naphtho[2,3-B]heteroar-4-yl derivatives |
| AU3791699A (en) * | 1998-05-12 | 1999-11-29 | American Home Products Corporation | Naphtho{2,3-b}heteroar-4-yl derivatives |
| US7045545B1 (en) | 1999-01-27 | 2006-05-16 | Eli Lilly And Company | Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists |
| EP1149085A1 (en) * | 1999-01-27 | 2001-10-31 | Eli Lilly And Company | Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists |
| DE19932314A1 (de) * | 1999-07-10 | 2001-01-11 | Merck Patent Gmbh | Benzofuranderivate |
| CA2394778A1 (en) * | 1999-12-16 | 2002-06-14 | Shiro Miyoshi | Novel substituted tricyclic compounds |
| ES2287120T3 (es) * | 2000-04-28 | 2007-12-16 | Asahi Kasei Pharma Corporation | Nuevos compuestos biciclicos. |
| AR035605A1 (es) | 2000-12-11 | 2004-06-16 | Bayer Corp | Derivados de aminometil cromano di-sustituidos, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos utiles como agonistas beta-3-adreno-receptores |
| AR035858A1 (es) | 2001-04-23 | 2004-07-21 | Bayer Corp | Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3 |
| WO2002100850A1 (fr) * | 2001-06-08 | 2002-12-19 | Kuraray Co., Ltd. | Procedes de preparation de composes heterocycliques |
| KR100816527B1 (ko) * | 2001-09-12 | 2008-04-10 | 한국화학연구원 | 페닐테트라졸 유도체로 치환된 β-아미노알코올 화합물 |
| DK1447400T3 (da) * | 2001-10-25 | 2008-12-08 | Asahi Kasei Pharma Corp | Bicyklisk forbindelse |
| US6864268B2 (en) | 2002-02-27 | 2005-03-08 | Pfizer Inc. | β3 adrenergic receptor agonists |
| EP1478625A1 (en) * | 2002-02-27 | 2004-11-24 | Pfizer Products Inc. | Processes and intermediates useful in preparing beta-3-adrenergic receptor agonists |
| AU2003209527A1 (en) * | 2002-02-27 | 2003-09-09 | Pfizer Products Inc. | Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
| US6844362B2 (en) | 2002-10-11 | 2005-01-18 | Pfizer Inc | Indole derivatives useful for the treatment of diseases |
| ATE392206T1 (de) * | 2002-10-11 | 2008-05-15 | Pfizer | Indolderivate als beta-2 agonisten |
| EP1407769A1 (en) * | 2002-10-11 | 2004-04-14 | Pfizer Limited | Indole derivatives as beta-2 agonists |
| JP2006514069A (ja) * | 2003-01-06 | 2006-04-27 | イーライ リリー アンド カンパニー | Ｐｐａｒ調節因子としての融合複素環式誘導体 |
| EP1460064A1 (en) * | 2003-03-14 | 2004-09-22 | Pfizer Limited | Indole-2-carboxamide derivatives useful as beta-2 agonists |
| MXPA05011841A (es) | 2003-05-09 | 2006-01-26 | Hoffmann La Roche | Metil-indoles y metil-pirrolopiridinas como agonistas adrenergicos de alfa-1. |
| JP2008100916A (ja) * | 2005-01-24 | 2008-05-01 | Dainippon Sumitomo Pharma Co Ltd | インドール類およびそれを含む医薬組成物 |
| US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| US20110160249A1 (en) | 2008-05-23 | 2011-06-30 | Schaab Kevin Murray | 5-lipoxygenase-activating protein inhibitor |
| EP2345644A4 (en) | 2008-10-09 | 2012-03-21 | Asahi Kasei Pharma Corp | INDAZOLE COMPOUND |
| EP2351742A4 (en) | 2008-10-09 | 2012-03-28 | Asahi Kasei Pharma Corp | indazole |
| US20100222404A1 (en) * | 2008-11-04 | 2010-09-02 | Asahi Kasei Pharma Corporation | Indazole derivative dihydrochloride |
| US20100173829A1 (en) * | 2008-11-07 | 2010-07-08 | Aston University | Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof |
| EP2563123B1 (en) * | 2010-04-30 | 2018-04-25 | Merck Sharp & Dohme Corp. | Novel beta 3 adrenergic receptor agonists |
| KR20230066313A (ko) | 2020-06-08 | 2023-05-15 | 탁토젠 인크 | 정신 장애 또는 정신적 증강에 유리한 벤조푸란 조성물 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1268960A (en) * | 1969-09-18 | 1972-03-29 | Sandoz Ltd | Indole derivatives |
| US3699123A (en) * | 1970-03-24 | 1972-10-17 | Sandoz Ltd | 4-(3-amino-2-hydroxy-propoxy) indole derivatives |
| EP0006735B1 (en) * | 1978-06-28 | 1983-06-15 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
| DE3061205D1 (en) * | 1979-06-16 | 1983-01-05 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
| DE3062216D1 (en) * | 1979-09-06 | 1983-04-07 | Beecham Group Plc | Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| ATE14222T1 (de) * | 1979-11-15 | 1985-07-15 | Beecham Group Plc | Sekundaere aethanolamine, ihre herstellung und ihre verwendung in pharmazeutischen zusammensetzungen. |
| CA1175851A (en) * | 1980-09-26 | 1984-10-09 | Beecham Group Limited | Secondary amines |
| GR75101B (no) * | 1980-10-23 | 1984-07-13 | Pfizer | |
| EP0052963B1 (en) * | 1980-11-20 | 1985-02-20 | Beecham Group Plc | Secondary amines |
| FR2523964B1 (fr) * | 1982-03-23 | 1985-09-27 | Sanofi Sa | Nouveaux derives de la tryptamine actifs notamment sur le systeme cardiovasculaire et procede pour leur preparation |
| JPS60202872A (ja) * | 1984-03-27 | 1985-10-14 | Kaken Pharmaceut Co Ltd | ベンゾフラン誘導体、その製法およびそれを有効成分とする降圧剤 |
| US4882433A (en) * | 1985-10-30 | 1989-11-21 | The Upjohn Company | 3'-pyridinylalkylinden- and 3'-pyridinylalkylindol-2-carboxylic acids and analogs |
| GB8528633D0 (en) * | 1985-11-21 | 1985-12-24 | Beecham Group Plc | Compounds |
| US4886814A (en) * | 1986-03-13 | 1989-12-12 | Dr. Karl Thomas Gmbh | Substituted thiazoles and oxazoles and 2-hydroxy-morpholines |
| GB8714901D0 (en) * | 1986-07-23 | 1987-07-29 | Ici Plc | Amide derivatives |
| GB8925032D0 (en) * | 1989-11-06 | 1989-12-28 | Ici Plc | Chemical compounds |
| US5061727A (en) * | 1990-05-04 | 1991-10-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
| US5106867A (en) * | 1990-05-04 | 1992-04-21 | American Cyanamid Company | Method of increasing lean meat in edible animals |
| JPH08165276A (ja) * | 1994-12-14 | 1996-06-25 | Dainippon Pharmaceut Co Ltd | ２−アルキルアミノ−１−フェニルエタノール誘導体 |
-
1994
- 1994-05-20 EP EP94914531A patent/EP0703911B1/en not_active Expired - Lifetime
- 1994-05-20 CZ CZ953277A patent/CZ327795A3/cs unknown
- 1994-05-20 ES ES94914531T patent/ES2104383T3/es not_active Expired - Lifetime
- 1994-05-20 US US08/569,152 patent/US5767133A/en not_active Expired - Fee Related
- 1994-05-20 AT AT94914531T patent/ATE154935T1/de not_active IP Right Cessation
- 1994-05-20 KR KR1019950705694A patent/KR960703120A/ko not_active Application Discontinuation
- 1994-05-20 BR BR9406823A patent/BR9406823A/pt not_active Application Discontinuation
- 1994-05-20 JP JP6520401A patent/JPH08506348A/ja active Pending
- 1994-05-20 DE DE69404039T patent/DE69404039T2/de not_active Expired - Fee Related
- 1994-05-20 CN CN94193087A patent/CN1129443A/zh active Pending
- 1994-05-20 PL PL94312005A patent/PL312005A1/xx unknown
- 1994-05-20 NZ NZ265692A patent/NZ265692A/en unknown
- 1994-05-20 CA CA002164009A patent/CA2164009A1/en not_active Abandoned
- 1994-05-20 AU AU66870/94A patent/AU675536B2/en not_active Ceased
- 1994-05-20 WO PCT/IB1994/000117 patent/WO1994029290A1/en not_active Application Discontinuation
- 1994-05-20 DK DK94914531.2T patent/DK0703911T3/da active
- 1994-06-06 IL IL10990494A patent/IL109904A0/xx unknown
- 1994-06-13 HU HU9401761A patent/HUT70844A/hu unknown
- 1994-06-13 ZA ZA944139A patent/ZA944139B/xx unknown
- 1994-06-13 FI FI942791A patent/FI942791A/fi not_active Application Discontinuation
-
1995
- 1995-12-13 NO NO955047A patent/NO955047D0/no unknown
-
1997
- 1997-07-16 GR GR970401784T patent/GR3024134T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI942791A0 (fi) | 1994-06-13 |
| DE69404039T2 (de) | 1997-10-16 |
| FI942791A (fi) | 1994-12-15 |
| AU675536B2 (en) | 1997-02-06 |
| EP0703911A1 (en) | 1996-04-03 |
| NZ265692A (en) | 1997-02-24 |
| HUT70844A (en) | 1995-11-28 |
| JPH08506348A (ja) | 1996-07-09 |
| US5767133A (en) | 1998-06-16 |
| NO955047L (no) | 1995-12-13 |
| ES2104383T3 (es) | 1997-10-01 |
| EP0703911B1 (en) | 1997-07-02 |
| HU9401761D0 (en) | 1994-09-28 |
| AU6687094A (en) | 1995-01-03 |
| IL109904A0 (en) | 1994-10-07 |
| WO1994029290A1 (en) | 1994-12-22 |
| CA2164009A1 (en) | 1994-12-22 |
| GR3024134T3 (en) | 1997-10-31 |
| PL312005A1 (en) | 1996-04-01 |
| DK0703911T3 (da) | 1997-10-06 |
| CN1129443A (zh) | 1996-08-21 |
| ZA944139B (en) | 1995-12-13 |
| ATE154935T1 (de) | 1997-07-15 |
| DE69404039D1 (de) | 1997-08-07 |
| KR960703120A (ko) | 1996-06-19 |
| CZ327795A3 (en) | 1996-08-14 |
| BR9406823A (pt) | 1996-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO955047D0 (no) | Sekundære aminer som antidiabetiske og antifedme-midler | |
| TR27835A (tr) | Sübstitüe edilmis azadiokzasikloalkenler. | |
| MX9702601A (es) | AGONISTAS beta-ADRENERGICOS HETEROCICLICOS. | |
| NO952321L (no) | Polypeptid, samt anti-HIV-preparat fremstilt fra dette | |
| PL320064A1 (en) | Application of dioxomorpholines for fighting against endoparasites, novel dioxomorphoines and method of obtaining them | |
| BR9406362A (pt) | Composto,processo para a preparação do mesmo e composição anti-nuclear | |
| FR2681784B1 (fr) | Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides. | |
| ES2131528T3 (es) | Nuevos polipeptidos y su uso. | |
| NO972623D0 (no) | Framasöytisk blanding omfattende lamotrigin | |
| ATE161178T1 (de) | Pyrazolpyridine für die behandlung der anämie | |
| TW261605B (no) | ||
| DE69109293D1 (de) | Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut. | |
| SE9401596D0 (sv) | New compounds | |
| FI963166A (fi) | Uusia merkaptoasetyyliamididisulfidijohdannaisia, jotka ovat käyttökelpoisia enkefalinaasin ja ACE:n inhibiittoreina | |
| DE59409923D1 (de) | Substituierte aminoalkylaminopyridine | |
| MX9705815A (es) | AGONISTAS beta-ADRENERGICOS. |